Ginkgo Bioworks Holdings (DNA) Long-Term Investments (2021 - 2023)
Ginkgo Bioworks Holdings posted quarterly Long-Term Investments of $1.1 million for Q3 2023, down 98.84% year-on-year from $96.3 million in Q3 2022, and down 99.07% on a QoQ basis from $119.9 million in Q2 2023.
Ginkgo Bioworks Holdings (DNA) has 3 years of Long-Term Investments data on file, last reported at $1.1 million in Q3 2023.
- For the quarter ending Q3 2023, Long-Term Investments fell 98.84% year-over-year to $1.1 million; the trailing twelve-month figure through Sep 2023 stood at $1.1 million (down 98.84% YoY), and the FY2022 full-year result was $1.5 million, down 88.31% from the prior year.
- Long-Term Investments for Q3 2023 stood at $1.1 million, down from $119.9 million in the prior quarter.
- Across five years, Long-Term Investments topped out at $1.7 billion in Q2 2021 and bottomed at $1.1 million in Q3 2023.
- The 3-year median for Long-Term Investments is $96.3 million (2022), against an average of $209.6 million.
- The widest annual swing landed in 2022, when Long-Term Investments plunged 99.6%; it then jumped 1634.8% in 2023.
- A 3-year view of Long-Term Investments shows it stood at $13.2 million in 2021, then sank by 88.31% to $1.5 million in 2022, then dropped by 27.41% to $1.1 million in 2023.
- The last three Long-Term Investments figures came in at $1.1 million (Q3 2023), $119.9 million (Q2 2023), and $121.8 million (Q1 2023), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Long-Term Investments (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | - |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | 505,194.89 |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | 5.75 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | 9.79 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | 22.17 Mn |
| 10 | Ginkgo Bioworks Holdings | 542.03 Mn | 542.03 Mn | 16.38 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2023 | 1.12 Mn |
| Jun 30, 2023 | 119.94 Mn |
| Mar 31, 2023 | 121.75 Mn |
| Dec 31, 2022 | 1.54 Mn |
| Sep 30, 2022 | 96.31 Mn |
| Jun 30, 2022 | 6.91 Mn |
| Mar 31, 2022 | 103.03 Mn |
| Dec 31, 2021 | 13.19 Mn |
| Sep 30, 2021 | 104.77 Mn |
| Jun 30, 2021 | 1.73 Bn |
| Mar 31, 2021 | 11.90 Mn |